Humana Inc. (NYSE:HUM) is High Ground Investment Management LLP's Largest Position

High Ground Investment Management LLP increased its stake in Humana Inc. (NYSE:HUM - Free Report) by 43.5% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 424,403 shares of the insurance provider's stock after buying an additional 128,636 shares during the period. Humana comprises about 33.4% of High Ground Investment Management LLP's investment portfolio, making the stock its largest position. High Ground Investment Management LLP owned approximately 0.35% of Humana worth $107,675,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also recently added to or reduced their stakes in the stock. Dynamic Technology Lab Private Ltd acquired a new stake in Humana during the third quarter worth about $404,000. Independent Advisor Alliance raised its position in shares of Humana by 68.3% during the 3rd quarter. Independent Advisor Alliance now owns 2,141 shares of the insurance provider's stock worth $678,000 after purchasing an additional 869 shares during the period. Bank of Montreal Can lifted its holdings in shares of Humana by 18.4% in the 3rd quarter. Bank of Montreal Can now owns 189,168 shares of the insurance provider's stock worth $60,452,000 after purchasing an additional 29,460 shares during the last quarter. FMR LLC boosted its position in Humana by 23.4% during the 3rd quarter. FMR LLC now owns 3,388,859 shares of the insurance provider's stock valued at $1,073,387,000 after purchasing an additional 643,291 shares during the period. Finally, Avestar Capital LLC grew its stake in Humana by 34.8% during the 3rd quarter. Avestar Capital LLC now owns 1,372 shares of the insurance provider's stock worth $435,000 after buying an additional 354 shares during the last quarter. 92.38% of the stock is owned by institutional investors and hedge funds.

Remove Ads

Wall Street Analysts Forecast Growth

A number of research analysts have issued reports on HUM shares. Barclays boosted their target price on shares of Humana from $255.00 to $270.00 and gave the company an "equal weight" rating in a research note on Thursday, February 13th. Piper Sandler boosted their price objective on Humana from $270.00 to $288.00 and gave the stock a "neutral" rating in a research report on Wednesday, January 15th. Cantor Fitzgerald restated a "neutral" rating and issued a $290.00 target price on shares of Humana in a research report on Wednesday, February 12th. JPMorgan Chase & Co. reduced their price target on Humana from $257.00 to $256.00 and set a "neutral" rating for the company in a research report on Tuesday, February 18th. Finally, Royal Bank of Canada restated an "outperform" rating and set a $283.00 price target on shares of Humana in a research report on Wednesday, February 12th. Eighteen investment analysts have rated the stock with a hold rating and five have issued a buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of "Hold" and an average target price of $285.68.

Humana Trading Up 0.3 %

Shares of HUM traded up $0.87 during midday trading on Tuesday, hitting $265.47. The stock had a trading volume of 278,885 shares, compared to its average volume of 1,561,418. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.68. The firm has a market cap of $32.04 billion, a P/E ratio of 26.68, a price-to-earnings-growth ratio of 2.05 and a beta of 0.57. Humana Inc. has a fifty-two week low of $213.31 and a fifty-two week high of $406.46. The business has a 50-day simple moving average of $269.77 and a two-hundred day simple moving average of $273.07.

Humana (NYSE:HUM - Get Free Report) last announced its earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share (EPS) for the quarter, beating the consensus estimate of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. As a group, equities analysts forecast that Humana Inc. will post 16.47 EPS for the current year.

Humana Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Friday, March 28th will be issued a dividend of $0.885 per share. This represents a $3.54 annualized dividend and a dividend yield of 1.33%. The ex-dividend date of this dividend is Friday, March 28th. Humana's dividend payout ratio is currently 35.58%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.